Device

Stytch Unveils the Most Complete Developer Toolkit for Passkeys

Retrieved on: 
Tuesday, December 5, 2023
Software, Technology, Security, Apps, Applications, MFA, Multi-factor authentication, Organization, Device, Risk, Fraud, FIDO Alliance, Android SDK, UI, Abstract, SSO, API, Single sign-on, Online shopping

Stytch offers the most robust toolkit for developers to build, implement, and customize passkey-based authentication, backed by the most comprehensive, flexible identity platform.

Key Points: 
  • Stytch offers the most robust toolkit for developers to build, implement, and customize passkey-based authentication, backed by the most comprehensive, flexible identity platform.
  • Stytch’s Passkeys offering:
    Provides the flexibility to integrate with web & mobile SDKs or a fully composable API: Stytch handles the complexities of building and implementing passkeys from scratch, so developers can implement passkeys with confidence.
  • Stytch’s Passkeys developer toolkit is now available and offered at no additional cost with the Stytch platform.
  • “Empowering developers with implementation tools is critical for mass adoption of passkeys -- it's great to see Stytch stepping up to fill this need."

Global Pain Management Drugs and Devices Market Report 2023 - Rising Demand for Minimally Invasive Pain Solutions - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 30, 2023
Pharmaceutical, Health, Medical Devices, DSM-IV codes, Grünenthal, Abbott Laboratories, Johnson & Johnson, Prevalence, Etanercept, Pain, Osteoarthritis, Disease, Pain management, Patient, Rheumatoid arthritis, Cancer pain, Geography, Quality of life, Neuropathic pain, Environment, AbbVie, Device, Poultry farming, Frankincense

The "Global Market for Pain Management Drugs and Devices" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Market for Pain Management Drugs and Devices" report has been added to ResearchAndMarkets.com's offering.
  • The global market for pain management drugs and devices was valued at $80.9 billion in 2022.
  • In addition, technological advancements are serving as a critical factor in the pain management drugs and devices market.
  • Based on products, the global pain management drugs and devices market is segmented into pharmaceuticals and medical devices.

US FDA Grants the BiVACOR Total Artificial Heart IDE Approval for First-in-Human Early Feasibility Study

Retrieved on: 
Wednesday, November 29, 2023
Cardiology, Biotechnology, FDA, Other Health, Health, General Health, Medical Devices, Research, Surgery, Science, Clinical Trials, Woman, Safety, Device, EFS, Exercise, Database, Patient, Male, The Texas Heart Institute, Heart, TAH, Heart failure, MD, Cardiac output, Dentistry, Medical device

The EFS will evaluate the safety and feasibility of BTAH as a bridge to a heart transplant in the treatment of subjects with biventricular heart failure.

Key Points: 
  • The EFS will evaluate the safety and feasibility of BTAH as a bridge to a heart transplant in the treatment of subjects with biventricular heart failure.
  • The study is anticipated to commence in 2024 and will pave the way for a subsequent pivotal study.
  • “I am eager to begin the BiVACOR Total Artificial Heart EFS to evaluate what I believe is a promising and potentially life-saving technology,” said Joseph Rogers, MD, National P.I.
  • “The FDA approval to begin The BiVACOR Total Artificial Heart EFS is a critical milestone for BiVACOR and is another validation of the remarkable work and accomplishments of the entire BiVACOR team.

Analog Devices to Participate in the UBS Global Technology Conference

Retrieved on: 
Wednesday, November 22, 2023
Software, Technology, Hardware, Semiconductor, ADI, Device, Conference, Analog Devices, Management, Broadcasting, Analog

Analog Devices, Inc. (Nasdaq: ADI ) today announced that the Company’s Chief Executive Officer & Chair of the Board of Directors, Vincent Roche, will discuss business topics and trends at the UBS Global Technology Conference taking place at The Phoenician Hotel, located in Scottsdale, Arizona, on Tuesday, November 28, 2023, at 2:55 p.m. Mountain Time.

Key Points: 
  • Analog Devices, Inc. (Nasdaq: ADI ) today announced that the Company’s Chief Executive Officer & Chair of the Board of Directors, Vincent Roche, will discuss business topics and trends at the UBS Global Technology Conference taking place at The Phoenician Hotel, located in Scottsdale, Arizona, on Tuesday, November 28, 2023, at 2:55 p.m. Mountain Time.
  • The webcast for the conference may be accessed live via the Investor Relations section of Analog Devices’ website at investor.analog.com .
  • An archived replay will also be available following the webcast for at least 30 days.

National Evaluation System for health Technology Coordinating Center (NESTcc) Selects Booz Allen Hamilton to Partner on Medical Device Active Surveillance Program

Retrieved on: 
Tuesday, November 21, 2023
White House, Federal Government, Public Policy, Government, Health, Medical Devices, Health Technology, Research, Science, Safety, Food, MDIC, Multimedia, CDRH, FDA, Data collection, Device, Medical device

The National Evaluation System for health Technology Coordinating Center (NESTcc), an initiative of the Medical Device Innovation Consortium (MDIC), announced today it has selected Booz Allen Hamilton to partner on the Central Data Operations Hub as part of an ongoing collaboration between the Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) to build an Active Surveillance Program for medical devices.

Key Points: 
  • The National Evaluation System for health Technology Coordinating Center (NESTcc), an initiative of the Medical Device Innovation Consortium (MDIC), announced today it has selected Booz Allen Hamilton to partner on the Central Data Operations Hub as part of an ongoing collaboration between the Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) to build an Active Surveillance Program for medical devices.
  • View the full release here: https://www.businesswire.com/news/home/20231121987503/en/
    NESTcc and the FDA intend to develop and implement an active surveillance system of electronic health data to better understand the safety of medical devices as used within clinical practice.
  • The active surveillance program is focused on achieving better data capture, detection of potential safety signals, and a timely assessment leading to actionable findings.
  • In addition, the data structure developed for the active surveillance system will be viable for generation of real-world evidence fit for purpose for regulatory decisions.

Element Science Announces Presentation of Successful Results of the Jewel® IDE Study in a Featured Science Presentation at the American Heart Association’s 2023 Annual Scientific Sessions

Retrieved on: 
Monday, November 13, 2023
Mobile, Wireless, Other Technology, Other Science, Software, Research, Networks, Internet, Hardware, Electronic Design Automation, Medical Devices, Data Management, Consumer Electronics, Hospitals, Wearables, Mobile Technology, Technology, Clinical Trials, Cardiology, Science, Biotechnology, Telemedicine, Virtual Medicine, Managed Care, General Health, Finance, Health, Artificial Intelligence, Health Technology, Professional Services, Safety, Device, Arrest, Success, Exercise, AHA, Risk, ICD, Patient, Sudden arrhythmic death syndrome, Death, Ventricular tachycardia, WCD, Survival, Health care, Jewel, Physician, Quality of life, American Heart, SCA, Ventricular fibrillation, Medical device, Pharmaceutical industry, Hospital

Element Science , an innovative health technology company pioneering a digital wearable platform for high-risk cardiovascular patients, today announced the successful completion and presentation of the results of the Jewel IDE Study.

Key Points: 
  • Element Science , an innovative health technology company pioneering a digital wearable platform for high-risk cardiovascular patients, today announced the successful completion and presentation of the results of the Jewel IDE Study.
  • Powered by a proprietary machine learning algorithm, the Jewel P-WCD also accurately detects abnormal heart rhythms resulting in a low false alarm rate and timely defibrillation when needed.
  • Dr. John Hummel, one of the study National Principal Investigators and the presenter of the study results at AHA ’23 stated, “The results of the Jewel IDE Study are extremely encouraging.
  • Element Science has concentrated its efforts on enhancing these patients' survival prospects by utilizing advancements in technology that bolster home-based care.

Orthopedic 3D printed devices market size to grow by USD 1.35 billion from 2023 to 2028 | North America to account for 40% of market growth- Technavio

Retrieved on: 
Thursday, December 14, 2023
EOS, Plastic, ROW, Renishaw plc, SLM Solutions Group AG, Research, 3D Systems, USD, Zimmer Biomet, Medtronic, Biomaterial, Instrument, Geography, Growth, 3D, Smith, Device, Medical device, Retail, 3D printing

NEW YORK, Dec. 14, 2023 /PRNewswire/ -- The orthopedic 3D printed devices market size is expected to grow by USD 1.35 billion from 2023 to 2028.

Key Points: 
  • NEW YORK, Dec. 14, 2023 /PRNewswire/ -- The orthopedic 3D printed devices market size is expected to grow by USD 1.35 billion from 2023 to 2028.
  • Orthopedic 3D Printed Devices Market: Segmentation Analysis
    The orthopedic implants segment is estimated to witness significant growth during the forecast period.
  • Detailed information on factors that will drive the growth of the orthopedic 3D printed devices market between 2023 and 2028.
  • Growth of the market across North America, Europe, Asia, and ROW
    Comprehensive analysis of factors that will challenge the growth of orthopedic 3D printed devices market companies.

Global Microfluidics Market Research Report 2023-2028: Expanding Applications of Drug Delivery Technologies and Opportunities in the Emergence of Microfluidic-Based 3D Cell Culture Systems

Retrieved on: 
Thursday, December 14, 2023
Microfluidics, POC, Device, Prevalence, Incidence, Investment, Microneedle drug delivery, USD, Point-of-care testing, Micropump, Miniaturization, COVID-19, Therapy, Component, Drug discovery, Growth, IVD, Proteomics, Hospital, Medical device, Pharmaceutical industry, Research

The report analyzes the microfluidics market and aims at estimating the market size and future growth potential of this market based on various segments such as product type, application, end user and region.

Key Points: 
  • The report analyzes the microfluidics market and aims at estimating the market size and future growth potential of this market based on various segments such as product type, application, end user and region.
  • The report also includes a product portfolio matrix of various microfluidic products available in the market.
  • The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.
  • In this report, the microfluidics market is broadly classified into three major application segments - in vitro diagnostics, pharmaceutical & life science research and manufacturing, and therapeutics.

The IEEE International Roadmap for Devices and Systems (IRDS) Emerges as a Global Leader for Chips Acts Visions and Programs

Retrieved on: 
Tuesday, December 12, 2023
SCR, 3DIC, Ecosystem, METI, European Chips Act, Multilateralism, Balestra, ITRS, Organization, International, Provinces of Greece, LOS, TFRC, IRC, Society, Ministry, IRDS, TIA, Keio University, Nanoelectronics, Siemens Digital Industries Software, NIST, ICOS, MOU, Device, IEEE, NSTC, WSC, IRCS, Electronics, IEEE CS, TSMC, Faculty, IAC, Task force, Visiting scholar, Consumer electronics, Mobile phone, Science, System, Semiconductor

LOS ALAMITOS, Calif., Dec. 12, 2023 /PRNewswire/ --The broad utilization of the IEEE International Roadmap for Devices and Systems (IRDS) is influencing the various Chips Acts worldwide.

Key Points: 
  • LOS ALAMITOS, Calif., Dec. 12, 2023 /PRNewswire/ --The broad utilization of the IEEE International Roadmap for Devices and Systems (IRDS) is influencing the various Chips Acts worldwide.
  • Initiatives in Europe, Japan, and the US are engaging the IRDS roadmap for guidance as their activities develop, said Tom Coughlin, President of IEEE.
  • IEEE International Roadmap for Devices and Systems maps the future for microelectronics industry.
  • The SiNANO Institute , European Academic and Scientific Association for Nanoelectronics and the Systems and Devices Roadmap of Japan (SDRJ) are founding members of IRDS.

University Lab Partners Announces Lionheart Health as the Winner of Golden Passport Pitch Competition to Accelerate Aesthetics Start-Ups

Retrieved on: 
Monday, December 11, 2023
ULP, Journal of Cosmetic Dermatology, Senior, Device, The Golden Passport, EB-5 visa, Associate, Science, AbbVie, Growth, Quality of life, UC, Industrial design, Dermatology

IRVINE, Calif., Dec. 11, 2023 /PRNewswire/ -- University Lab Partners (ULP) announces Lionheart Health as the winner of the inaugural Golden Passport Pitch Competition, sponsored by Allergan Aesthetics, an AbbVie Company.

Key Points: 
  • IRVINE, Calif., Dec. 11, 2023 /PRNewswire/ -- University Lab Partners (ULP) announces Lionheart Health as the winner of the inaugural Golden Passport Pitch Competition, sponsored by Allergan Aesthetics, an AbbVie Company.
  • Lionheart Health will be awarded a 1-year sponsored lab bench at University Lab Partners, the premier wet lab incubator in Irvine, CA.
  • In addition, Lionheart Health's team will have the opportunity to engage with industry mentors including scientific and business leaders from Allergan Aesthetics and ULP.
  • Howard Leonhardt, Founder and CEO of Lionheart Health shared, "We are grateful for the Golden Passport opportunity offered through Allergan Aesthetics and University Lab Partners.